Journal articles on the topic 'Aminobisphosphonate'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Aminobisphosphonate.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Das, Hiranmoy, Lisheng Wang, Arati Kamath, and Jack F. Bukowski. "Vγ2Vδ2 T-cell receptor–mediated recognition of aminobisphosphonates." Blood 98, no. 5 (September 1, 2001): 1616–18. http://dx.doi.org/10.1182/blood.v98.5.1616.
Full textEndo, Yasuo, Masahiko Shibazaki, Kouji Yamaguchi, Masanori Nakamura, and Hiroshi Kosugi. "Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate." British Journal of Pharmacology 126, no. 4 (February 1999): 903–10. http://dx.doi.org/10.1038/sj.bjp.0702367.
Full textKantoci, Darko, J. Kane Denike, and William J. Wechter. "Synthesis of Aminobisphosphonate." Synthetic Communications 26, no. 10 (May 1996): 2037–43. http://dx.doi.org/10.1080/00397919608003560.
Full textKANTOCI, D., J. K. DENIKE, and W. J. WECHTER. "ChemInform Abstract: Synthesis of Aminobisphosphonate." ChemInform 27, no. 34 (August 5, 2010): no. http://dx.doi.org/10.1002/chin.199634177.
Full textCairo, Cristiana, Bertrand Sagnia, Giulia Cappelli, Rose Leke, Robert Leke, Vittorio Colizzi, and C. Pauza. "Repertoire selection and effector functions of neonatal γδ T cells (85.12)." Journal of Immunology 184, no. 1_Supplement (April 1, 2010): 85.12. http://dx.doi.org/10.4049/jimmunol.184.supp.85.12.
Full textKuźnik, Anna, Dominika Kozicka, Wioleta Hawranek, Karolina Socha, and Karol Erfurt. "One-Pot and Catalyst-Free Transformation of N-Protected 1-Amino-1-Ethoxyalkylphosphonates into Bisphosphonic Analogs of Protein and Non-Protein α-Amino Acids." Molecules 27, no. 11 (June 2, 2022): 3571. http://dx.doi.org/10.3390/molecules27113571.
Full textMeraviglia, Serena, Carmela La Mendola, Valentina Orlando, Francesco Scarpa, Giuseppe Cicero, and Francesco Dieli. "Vγ9Vδ2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies." Oncology Reviews 4, no. 4 (December 14, 2011): 211. http://dx.doi.org/10.4081/oncol.2010.211.
Full textNAKASHIMA, Mitsuyoshi, Mitsutaka KANAMARU, and Norihiro TAKENAGA. "Phase I Study of Alendronate, a New Aminobisphosphonate." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 26, no. 2 (1995): 475–89. http://dx.doi.org/10.3999/jscpt.26.475.
Full textLiu, Chia-Yuan, Po-Sheng Yang, Shih-Ping Cheng, Yu-Chuen Huang, Jie-Jen Lee, Chun-Chuan Ko, Hui-Ru Shieh, and Yu-Jen Chen. "Zoledronic acid, an aminobisphosphonate, prolongs survival of skin allografts." Clinical & Investigative Medicine 35, no. 4 (August 4, 2012): 165. http://dx.doi.org/10.25011/cim.v35i4.17144.
Full textMoon, Myung-Sang, Ki-Tae Kwon, Chang-Won Ha, Sung-Soo Kim, Sung Sim Kim, and Hanlim Moon. "BONE HISTOLOGY OF PATIENTS WITH ALENDRONATE-MEDIATED FRACTURED BONE — A NEW ENTITY OF ATYPICAL OSTEOMALACIA." Journal of Musculoskeletal Research 17, no. 03 (September 2014): 1450011. http://dx.doi.org/10.1142/s0218957714500110.
Full textLópez-Francés, Adrián, Francisco Palacios, Aitor Maestro, and Javier Vicario. "Diethyl(benzamido(diisopropoxyphosphoryl)methyl)phosphonate." Molbank 2022, no. 3 (August 11, 2022): M1424. http://dx.doi.org/10.3390/m1424.
Full textBachler, Patricia R., Michael D. Schulz, Chelsea A. Sparks, Kenneth B. Wagener, and Brent S. Sumerlin. "Aminobisphosphonate Polymers via RAFT and a Multicomponent Kabachnik-Fields Reaction." Macromolecular Rapid Communications 36, no. 9 (March 24, 2015): 828–33. http://dx.doi.org/10.1002/marc.201500060.
Full textHARINCK, H. I. J., OLAV L. M. BIJVOET, H. J. BLANKSMA, and P. J. DAHLINGHAUS-NIENHUYS. "Efficacious Management with Aminobisphosphonate (APD) in Paget??s Disease of Bone." Clinical Orthopaedics and Related Research &NA;, no. 217 (April 1987): 79???98. http://dx.doi.org/10.1097/00003086-198704000-00010.
Full textEhrick, Robin S., Marcello Capaccio, David A. Puleo, and Leonidas G. Bachas. "Ligand-Modified Aminobisphosphonate for Linking Proteins to Hydroxyapatite and Bone Surface." Bioconjugate Chemistry 19, no. 1 (January 2008): 315–21. http://dx.doi.org/10.1021/bc700196q.
Full textPrice, R., A. Fenton, N. Kent, D. Gutteridge, C. Bhagat, B. Stuckey, and R. Retallack. "Intravenous aminobisphosphonate (APD) in Paget's disease: Clinical, biochemical and histomorphometric responses." Bone and Mineral 10, no. 3 (September 1990): S318. http://dx.doi.org/10.1016/0169-6009(90)90377-r.
Full textRoldán, EJA, OJ Dearossi, M. Gongalves, JC Barreira, D. Messina, EM Kerzberg, E. Montuori, and A. Pérez Lloret. "Human serum kinetics of a new aminobisphosphonate labelled with 99m Tc." Bone and Mineral 17 (April 1992): S18. http://dx.doi.org/10.1016/0169-6009(92)92285-x.
Full textFenton, Anna J., Donald H. Gutteridge, G. Nell Kent, Roger I. Price, Robert W. Retallack, Chotoo I. Bhagat, Graeme K. Worth, et al. "Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses." Clinical Endocrinology 34, no. 3 (March 1991): 197–204. http://dx.doi.org/10.1111/j.1365-2265.1991.tb00294.x.
Full textTan, Paul L. J., June M. Katz, Ruth Ames, David E. Caughey, Harley D. Gray, H. Kaye Ibbertson, and James D. Watson. "Aminobisphosphonate inhibition of interleukin-1—induced bone resorption in mouse calvariae." Arthritis & Rheumatism 31, no. 6 (June 1988): 762–68. http://dx.doi.org/10.1002/art.1780310610.
Full textVeena, HR, and Deepak Prasad. "Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects." Journal of Indian Society of Periodontology 14, no. 1 (2010): 40. http://dx.doi.org/10.4103/0972-124x.65438.
Full textNakamura, Masanori, Hideki Yagi, Yasuo Endo, Hiroshi Kosugi, Tadashi Ishi, and Tsunetoshi Itoh. "A time kinetic study of the effect of aminobisphosphonate on murine haemopoiesis." British Journal of Haematology 107, no. 4 (December 1999): 779–90. http://dx.doi.org/10.1046/j.1365-2141.1999.01774.x.
Full textChen, Yu-Jen, K. S. Clifford Chao, Yuh-Cheng Yang, Ming-Ling Hsu, Chin-Ping Lin, and Yu Yawn Chen. "Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells." Immunopharmacology and Immunotoxicology 31, no. 3 (April 2009): 499–508. http://dx.doi.org/10.1080/08923970902814103.
Full textWeinstein, Robert S. "Long-Term Aminobisphosphonate Treatment of Fibrous Dysplasia: Spectacular Increase in Bone Density." Journal of Bone and Mineral Research 12, no. 8 (August 1, 1997): 1314–15. http://dx.doi.org/10.1359/jbmr.1997.12.8.1314.
Full textCallan, John F., Sukanta Kamila, Narinder Singh, Ray C. Mulrooney, Martha MacKay, Maedhbh C. Cronin, John Dunn, and David G. Durham. "A new class of fluorescent chemosensors based on the β-aminobisphosphonate receptor." Supramolecular Chemistry 21, no. 7 (September 22, 2009): 643–49. http://dx.doi.org/10.1080/10610270802709352.
Full textRichards, P. J., N. Amos, A. S. Williams, and B. D. Williams. "Pro-inflammatory effects of the aminobisphosphonate ibandronate in vitro and in vivo." Rheumatology 38, no. 10 (October 1999): 984–91. http://dx.doi.org/10.1093/rheumatology/38.10.984.
Full textCaccamo, Nadia, Serena Meraviglia, Francesco Scarpa, Carmela La Mendola, Daniele Santini, Cesira T. Bonanno, Gabriella Misiano, Francesco Dieli, and Alfredo Salerno. "Aminobisphosphonate-activated γδ T cells in immunotherapy of cancer: doubts no more." Expert Opinion on Biological Therapy 8, no. 7 (June 12, 2008): 875–83. http://dx.doi.org/10.1517/14712598.8.7.875.
Full textKeller, R. Kennedy, and Steven J. Fliesler. "Mechanism of Aminobisphosphonate Action: Characterization of Alendronate Inhibition of the Isoprenoid Pathway." Biochemical and Biophysical Research Communications 266, no. 2 (December 1999): 560–63. http://dx.doi.org/10.1006/bbrc.1999.1849.
Full textGutteridge, D. H., L. C. Ward, G. O. Stewart, R. W. Retallack, R. K. Will, R. L. Prince, A. Criddle, et al. "Paget's disease: Acquired resistance to one aminobisphosphonate with retained response to another." Journal of Bone and Mineral Research 14, S2 (November 1999): 79–84. http://dx.doi.org/10.1002/jbmr.5650140216.
Full textRendina, Domenico, Gianpaolo De Filippo, Daniela Merlotti, Marco Di Stefano, Christian Mingiano, Alfonso Giaquinto, Marco Evangelista, et al. "Increased Prevalence of Nephrolithiasis and Hyperoxaluria in Paget Disease of Bone." Journal of Clinical Endocrinology & Metabolism 105, no. 12 (August 22, 2020): e4430-e4438. http://dx.doi.org/10.1210/clinem/dgaa576.
Full textHo, Andrew YY, and Annie WC Kung. "Efficacy and Tolerability of Alendronate Once Weekly in Asian Postmenopausal Osteoporotic Women." Annals of Pharmacotherapy 39, no. 9 (September 2005): 1428–33. http://dx.doi.org/10.1345/aph.1e580.
Full textYamamoto, Michiko, Angelo Markatos, J. Gregory Seedor, Patricia Masarachia, Michael Gentile, Gideon A. Rodan, and Raffaella Balena. "The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats." Calcified Tissue International 53, no. 4 (October 1993): 278–82. http://dx.doi.org/10.1007/bf01320914.
Full textTAN, P. L. J., R. AMES, S. YEOMAN, H. K. IBBERTSON, and D. E. CAUGHEY. "EFFECTS OF AMINOBISPHOSPHONATE INFUSION ON BIOCHEMICAL INDICES OF BONE METABOLISM IN RHEUMATOID ARTHRITIS." Rheumatology 28, no. 4 (1989): 325–28. http://dx.doi.org/10.1093/rheumatology/28.4.325.
Full textLandman, J. O., N. A. T. Hamdy, E. K. J. Pauwels, and S. E. Papapoulos. "Continuous aminobisphosphonate (pamidronate) treatment of osteoporosis; maintained beneficial effects beyond 3 years of therapy." Osteoporosis International 6, S1 (January 1996): 265. http://dx.doi.org/10.1007/bf02500597.
Full textHooper, M., P. Clifton-Bligh, G. Marel, F. Lang, J. Tancred, D. McDowall, and L. Forman. "A single day intravenous infusion of aminobisphosphonate (pamidronate) for the treatment of paget's disease." Bone and Mineral 17 (April 1992): 224. http://dx.doi.org/10.1016/0169-6009(92)92231-e.
Full textHooper, M., P. Clifton-Bligh, G. Marel, F. Lang, J. Tancre, D. McDowall, and L. Forman. "A single day intravenous infusion of aminobisphosphonate (pamidronate) for the treatment of Paget's disease." Bone and Mineral 17 (April 1992): S30. http://dx.doi.org/10.1016/0169-6009(92)92326-l.
Full textBenelli, Roberto, Delfina Costa, Laura Salvini, Samuele Tardito, Francesca Tosetti, Federico Villa, Maria Raffaella Zocchi, and Alessandro Poggi. "Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab." Journal for ImmunoTherapy of Cancer 10, no. 12 (December 2022): e005660. http://dx.doi.org/10.1136/jitc-2022-005660.
Full textJosse, S., C. Faucheux, A. Soueidan, G. Grimandi, D. Massiot, B. Alonso, Pascal Janvier, et al. "A Novel Drug Delivery System for Bisphosphonates: Innovative Strategy for Local Treatment of Bone Resorption." Key Engineering Materials 284-286 (April 2005): 399–402. http://dx.doi.org/10.4028/www.scientific.net/kem.284-286.399.
Full textLorimier, L. P., T. M. Fan, S. C. Charney, H. I. Lacoste, D. A. Heller, M. M. Endicott, and C. H. Souza. "Monitoring response to aminobisphosphonate therapy in canine osteosarcoma using dual energy x-ray absorptiometry (dexa)." Veterinary and Comparative Oncology 2, no. 2 (June 2004): 101–2. http://dx.doi.org/10.1111/j.1476-5810.2004.0045e.x.
Full textAdami, Silvano, Vania Braga, Giancesare Guidi, Davide Gatti, Daniela Gerardi, and Elena Fracassi. "Chronic Intravenous Aminobisphosphonate Therapy Increases High-Density Lipoprotein Cholesterol and Decreases Low-Density Lipoprotein Cholesterol." Journal of Bone and Mineral Research 15, no. 3 (February 18, 2010): 599–604. http://dx.doi.org/10.1359/jbmr.2000.15.3.599.
Full textMarcuzzi, Annalisa, Alberto Tommasini, Sergio Crovella, and Alessandra Pontillo. "Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes." International Immunopharmacology 10, no. 6 (June 2010): 639–42. http://dx.doi.org/10.1016/j.intimp.2010.03.008.
Full textGibbons, C. L. M. H., M. Petra, R. Smith, and N. A. Athanasou. "Bisphosphonate Treatment of Benign Multifocal and Unifocal Osteolytic Tumours of Bone." Sarcoma 7, no. 1 (2003): 35–41. http://dx.doi.org/10.1080/1357714031000114165.
Full textTu, Wenwei, Jian Zheng, Yinping Liu, Sin Fun Sia, Ming Liu, Gang Qin, Iris H. Y. Ng, et al. "The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a γδ T cell population in humanized mice." Journal of Experimental Medicine 208, no. 7 (June 27, 2011): 1511–22. http://dx.doi.org/10.1084/jem.20110226.
Full textKamila, Sukanta, John F. Callan, Ray C. Mulrooney, and Moira Middleton. "A novel fluorescent chemosensor for Cu(II) in aqueous solution based on a β-aminobisphosphonate receptor." Tetrahedron Letters 48, no. 44 (October 2007): 7756–60. http://dx.doi.org/10.1016/j.tetlet.2007.09.029.
Full textAlonzo, E., E. Bellorin-Font, R. Carlini, V. Paz-Martínez, and J. R. Weisinger. "Role of the bone in the pathogenesis of idiopathic hypercalciuria (IH): Effect of aminobisphosphonate alendronate (ALN)." Osteoporosis International 6, S1 (January 1996): 286. http://dx.doi.org/10.1007/bf02500680.
Full textCabillic, Florian, Olivier Toutirais, Vincent Lavoué, Cécile Thomas de La Pintière, Pascale Daniel, Nathalie Rioux-Leclerc, Bruno Turlin, et al. "Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients." Cancer Immunology, Immunotherapy 59, no. 11 (June 26, 2010): 1611–19. http://dx.doi.org/10.1007/s00262-010-0887-0.
Full textBalooch, Guive, Wei Yao, Joel W. Ager, Mehdi Balooch, Ravi K. Nalla, Alexandra E. Porter, Robert O. Ritchie, and Nancy E. Lane. "The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids." Arthritis & Rheumatism 56, no. 11 (2007): 3726–37. http://dx.doi.org/10.1002/art.22976.
Full textDavison, Mario R., Leonardo Lyardet, Mariana Preliasco, Graciela Yaful, Perla Torres, Marina S. Bonanno, Gretel G. Pellegrini, and Susana N. Zeni. "Aminobisphosphonate‐treated ewes as a model of osteonecrosis of the jaw and of dental implant failure." Journal of Periodontology 91, no. 5 (December 15, 2019): 628–37. http://dx.doi.org/10.1002/jper.19-0213.
Full textEvans, K. D., L. E. Sheppard, D. I. Grossman, S. H. Rao, R. B. Martin, and A. M. Oberbauer. "Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse." Open Orthopaedics Journal 2, no. 1 (July 14, 2008): 121–25. http://dx.doi.org/10.2174/1874325000802010121.
Full textLee, Dae Ho. "The management of osteoporosis." Journal of Medicine and Life Science 7, no. 1 (June 1, 2010): 35–40. http://dx.doi.org/10.22730/jmls.2010.7.1.35.
Full textBabaji, Prashant, Rajni Aggarwal, SSenthil Nathan, George Attokaran, SM Santosh Kumar, and Sharanpriya Sathnoorkar. "Comparative clinicoradiographical evaluation of effect of aminobisphosphonate (sodium alendronate) on peri-implant bone status: Controlled clinical trial." Journal of International Society of Preventive and Community Dentistry 6, no. 4 (2016): 285. http://dx.doi.org/10.4103/2231-0762.184039.
Full textWalsh, Mairéad, Glennis White, Kenneth Romeril, Huib Buyck, Matthew Stephens, Collin Brooks, and Robert Weinkove. "Innate-like T cell profile in myeloma: Severe deficiency of Vγ9Vδ2 T cells in aminobisphosphonate-treated patients." Leukemia & Lymphoma 57, no. 4 (October 9, 2015): 977–80. http://dx.doi.org/10.3109/10428194.2015.1088653.
Full text